These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24063949)

  • 1. Cross-talk between estradiol receptor and EGFR/IGF-IR signaling pathways in estrogen-responsive breast cancers: focus on the role and impact of proteoglycans.
    Skandalis SS; Afratis N; Smirlaki G; Nikitovic D; Theocharis AD; Tzanakakis GN; Karamanos NK
    Matrix Biol; 2014 Apr; 35():182-93. PubMed ID: 24063949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin-like growth factor receptor in the expression of cell surface heparan sulfate proteoglycans and cell motility in breast cancer cells.
    Tsonis AI; Afratis N; Gialeli C; Ellina MI; Piperigkou Z; Skandalis SS; Theocharis AD; Tzanakakis GN; Karamanos NK
    FEBS J; 2013 May; 280(10):2248-59. PubMed ID: 23374155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistance.
    Knowlden JM; Jones HE; Barrow D; Gee JM; Nicholson RI; Hutcheson IR
    Breast Cancer Res Treat; 2008 Sep; 111(1):79-91. PubMed ID: 17902048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17 beta -estradiol-mediated vessel assembly and stabilization in tumor angiogenesis requires TGF beta and EGFR crosstalk.
    Soares R; Guo S; Gärtner F; Schmitt FC; Russo J
    Angiogenesis; 2003; 6(4):271-81. PubMed ID: 15166495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-talk among estrogen receptor, epidermal growth factor, and insulin-like growth factor signaling in breast cancer.
    Lee AV; Cui X; Oesterreich S
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4429s-4435s; discussion 4411s-4412s. PubMed ID: 11916236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane initiated estrogen signaling in breast cancer.
    Song RX; Santen RJ
    Biol Reprod; 2006 Jul; 75(1):9-16. PubMed ID: 16571873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-talk between IGF-I and estradiol in the brain: focus on neuroprotection.
    Garcia-Segura LM; Sanz A; Mendez P
    Neuroendocrinology; 2006; 84(4):275-9. PubMed ID: 17124377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor.
    Levin ER
    Mol Endocrinol; 2003 Mar; 17(3):309-17. PubMed ID: 12554774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of signaling cross-talks contributing to acquired drug resistance in breast cancer cells by Bayesian statistical modeling.
    Azad AK; Lawen A; Keith JM
    BMC Syst Biol; 2015 Jan; 9():2. PubMed ID: 25599599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of receptor complexes in the extranuclear actions of estrogen receptor alpha in breast cancer.
    Song RX; Fan P; Yue W; Chen Y; Santen RJ
    Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S3-13. PubMed ID: 17259556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer effect of genistein on BG-1 ovarian cancer growth induced by 17 β-estradiol or bisphenol A via the suppression of the crosstalk between estrogen receptor α and insulin-like growth factor-1 receptor signaling pathways.
    Hwang KA; Park MA; Kang NH; Yi BR; Hyun SH; Jeung EB; Choi KC
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):637-46. PubMed ID: 23933164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib.
    Morgillo F; Woo JK; Kim ES; Hong WK; Lee HY
    Cancer Res; 2006 Oct; 66(20):10100-11. PubMed ID: 17047074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
    Cui X; Kim HJ; Kuiatse I; Kim H; Brown PH; Lee AV
    Cancer Res; 2006 May; 66(10):5304-13. PubMed ID: 16707456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex hormone-binding globulin (SHBG) and estradiol cross-talk in breast cancer cells.
    Fortunati N; Catalano MG
    Horm Metab Res; 2006 Apr; 38(4):236-40. PubMed ID: 16700004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
    Nicholl SM; Roztocil E; Davies MG
    J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalk.
    Massarweh S; Schiff R
    Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S15-24. PubMed ID: 17259554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-talk between estrogen receptors and insulin-like growth factor-I receptor in the brain: cellular and molecular mechanisms.
    Mendez P; Wandosell F; Garcia-Segura LM
    Front Neuroendocrinol; 2006 Dec; 27(4):391-403. PubMed ID: 17049974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.